Jump Financial’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.25M Buy
+92,606
New +$6.31M 0.06% 368
2026
Q1
Sell
-6,328
Closed -$426K 2093
2025
Q4
$426K Sell
6,328
-35,451
-85% -$2.38M 0.01% 1384
2025
Q3
$3.06M Buy
41,779
+29,870
+251% +$1.98M 0.04% 564
2025
Q2
$620K Buy
+11,909
New +$678K 0.01% 1154
2024
Q4
Sell
-58,400
Closed -$3.34M 1798
2024
Q3
$3.34M Buy
+58,400
New +$3.35M 0.07% 334
2023
Q1
Sell
-8,270
Closed -$471K 1772
2022
Q4
$471K Buy
+8,270
New +$423K 0.02% 802
2022
Q3
Sell
-65,159
Closed -$2.87M 1730
2022
Q2
$2.87M Buy
+65,159
New +$2.82M 0.12% 226
2021
Q3
Sell
-39,861
Closed -$1.81M 1248
2021
Q2
$1.81M Buy
+39,861
New +$1.76M 0.17% 129
2021
Q1
Sell
-5,012
Closed -$214K 1078
2020
Q4
$214K Buy
+5,012
New +$180K 0.04% 754

Other funds holding HALO

Jump Financial's HALO Position: Q2 2026 in Review

Jump Financial opened a new position in Halozyme (HALO) in Q2 2026: 92,606 shares worth $7.25M. The stake represents 0.06% of the portfolio and ranks #368 among its holdings. This is a return to the name: Jump Financial previously reported a position in HALO as recently as Q4 2025.

Jump Financial first reported a position in HALO in Q4 2020 and has held it in 9 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Jump Financial held 92,606 shares of Halozyme worth $7.25M as of Q2 2026.
  • Halozyme was a new Jump Financial position in Q2 2026.
  • Halozyme made up 0.06% of Jump Financial's portfolio in Q2 2026, its #368 holding.
  • Jump Financial first reported a position in Halozyme in Q4 2020 and has held it in 9 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.